arrow_back Back to App

Recognition for Operation Warp Speed and COVID-19 Vaccine Development

This Senate resolution expresses appreciation for the previous administration's creation of Operation Warp Speed, which significantly accelerated the development and distribution of COVID-19 vaccines. Thanks to this program, vaccines became available much faster than usual, helping to combat the pandemic and protect public health in the United States.
Key points
Rapid Vaccine Development: The program enabled the creation and authorization of COVID-19 vaccines in just 9 months, instead of years.
Vaccine Availability: Support for vaccine manufacturing and distribution, including the procurement of millions of doses, accelerated their availability to citizens.
Protection for At-Risk Groups: Public-private partnerships helped quickly deliver vaccines to nursing homes and long-term care facilities, protecting the most vulnerable.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_188
Sponsor: Sen. Marshall, Roger [R-KS]
Process start date: 2021-04-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing appreciation and recognition for the Trump Administration for the creation of Operation Warp Speed and the historic development of a COVID-19 vaccine.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_188.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-28.

What are the main provisions?

Key points include:

  • Rapid Vaccine Development: The program enabled the creation and authorization of COVID-19 vaccines in just 9 months, instead of years.
  • Vaccine Availability: Support for vaccine manufacturing and distribution, including the procurement of millions of doses, accelerated their availability to citizens.
  • Protection for At-Risk Groups: Public-private partnerships helped quickly deliver vaccines to nursing homes and long-term care facilities, protecting the most vulnerable.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Marshall, Roger [R-KS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health